Vancouver, Canada – Virogin Biotech is pleased to announce the completion of its Series C round of financing for a total of $62 million USD on September 20, 2020. Virogin… Read More
Industry innovator developing clinically proven, pharmaceutical grade health products adds experienced pharmaceutical executive to its team VANCOUVER, B.C. September 28, 2020/ ImmunoFlex™, a life sciences company developing clinically validated, pharmaceutical… Read More
Voclosporin ophthalmic solution (VOS) results on track to be reported in the fourth quarter of 2020 Study builds on positive head-to-head data with approved treatment reported in prior Phase 2a… Read More
Phase 1 Trial to Evaluate ZT-01 for the Prevention of Insulin-Induced Hypoglycemia in Patients with Type 1 Diabetes Toronto, Canada, September 29, 2020 – Zucara Therapeutics Inc., a diabetes life… Read More
Vancouver, BC – September 24, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
